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Abstract
We conducted a randomized controlled trial (RCT) of an early palliative care
intervention (ENABLE: Educate, Nurture, Advise, Before Life Ends) for persons
with advanced cancer and their family caregivers. Not all patient participants
had a caregiver coparticipant; hence, we explored whether there were relationships between patient survival, having an enrolled caregiver, and caregiver outcomes prior to death. One hundred and twenty-three patient-caregiver dyads
and 84 patients without a caregiver coparticipant participated in the ENABLE
early versus delayed (12 weeks later) RCT. We collected caregiver quality-of-life
(QOL), depression, and burden (objective, stress, and demand) measures every
6 weeks for 24 weeks and every 3 months thereafter until the patient’s death
or study completion. We conducted survival analyses using log-rank and Cox
proportional hazards models. Patients with a caregiver coparticipant had significantly shorter survival (Wald = 4.31, HR = 1.52, CI: 1.02–2.25, P = 0.04).
After including caregiver status, marital status (married/unmarried), their
interaction, and relevant covariates, caregiver status (Wald = 6.25, HR = 2.62,
CI: 1.23–5.59, P = 0.01), being married (Wald = 8.79, HR = 2.92, CI: 1.44–5.91,
P = 0.003), and their interaction (Wald = 5.18, HR = 0.35, CI: 0.14–0.87,
P = 0.02) were significant predictors of lower patient survival. Lower survival
in patients with a caregiver was significantly related to higher caregiver demand
burden (Wald = 4.87, CI: 1.01–1.20, P = 0.03) but not caregiver QOL, depression, and objective and stress burden. Advanced cancer patients with caregivers
enrolled in a clinical trial had lower survival than patients without caregivers;
however, this mortality risk was mostly attributable to higher survival by
unmarried patients without caregivers. Higher caregiver demand burden was
also associated with decreased patient survival.
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Introduction
We conducted a fast track randomized controlled trial
(RCT) with 207 newly diagnosed advanced cancer patients
and 123 family caregivers to test the ENABLE III (Educate,
Nurture, Advise, Before Life Ends) nurse-led, telephone-
based palliative care intervention. This RCT demonstrated
that concurrent palliative care initiated soon after a diagnosis of advanced cancer had beneficial effects on patient
survival and caregiver depression and burden compared
with initiating this intervention 12 weeks later [1, 2].
Because we enrolled patient participants with and without
family caregivers, we had a “natural” experiment [3] allowing us to examine whether the presence of a caregiver
and a caregiver’s wellbeing and burden might also be
related to patient survival.
Caregivers perform a plethora of health-related tasks
that appear vital for advanced cancer patients’ survival.
They spend an average of 8 h/day [4] tracking and
treating symptoms; administering medications and
breathing treatments; coordinating medical appointments; participating in advance care planning and other
healthcare decision-
making; providing emotional and
spiritual support; preparing meals; managing finances;
and performing domestic home duties [5–8]. Over time,
however, caregivers may become burdened by performing these tasks.
Part of this burden relates to caregivers feeling untrained
and unprepared [6, 8, 9], while other parts relate to witnessing someone close to them struggle with serious illness.
Thus, caregivers become prone to depression [10], anxiety
[11], and poor physical health [12, 13]. As the Institute
of Medicine [14] and others [15, 16] have reported, this
poor caregiver health can attenuate a caregiver’s ability
to provide care to cancer patients. This line of reasoning
served as the impetus for us to include a parallel intervention specifically for family caregivers in the ENABLE
III trial. Nurse coaches provided one-on-one support and
education to caregivers about caregiving tasks, and about
how to cope with their care recipients’ struggle with serious illness. We believed this would improve caregivers’
wellbeing and performance thus benefiting cancer patients’
wellbeing and survival. Indeed, the main results of our
trial demonstrated that caregivers had lower depressed
mood and stress burden [2].
However, two unanswered questions remained: (1) What
relationship exists between having a family caregiver and
a patient’s survival? (2) What relationships exist between
a caregiver’s outcomes (quality-of-life [QOL], depression,
and burden) and a patient’s survival? To address these
questions, we conducted a secondary analysis of our clinical trial data. We hypothesized that having a caregiver
would be associated with increased patient survival, and
854

J. Nicholas Dionne-Odom et al.

that higher caregiver QOL and lower caregiver depression
and burden would be associated with increased patient
survival.

Methods
This was a secondary analysis of the ENABLE III [1, 2]
“fast track” RCT [17]. Individuals with newly diagnosed,
recurrent, or progressive metastatic cancer and their caregivers (if they had one and were willing to enroll) were
randomly assigned to receive the intervention as soon as
possible after diagnosis (early group) or 12 weeks later
(delayed group). The study protocol, data and safety
monitoring plan were approved by the Norris Cotton
Cancer Center/Dartmouth College and the Veterans
Administration (VA) Medical Center, White River Junction,
Vermont institutional review boards. The trial was
registered in clinicaltrials.gov (Identifier NCT01245621).

Sample and setting
Patient and caregiver participants in the ENABLE III trial
were recruited between October 11, 2010 and March 5,
2013 from the Norris Cotton Cancer Center at Dartmouth-
Hitchcock Medical Center (DHMC), affiliated DHMC
outreach clinics, and the White River Junction, Vermont
VA Medical Center. Patient inclusion criteria were: (1)
age >18 years; (2) within 30–60 days of being informed
by a treating oncologist of a new diagnosis, recurrence,
or progression of an advanced-stage cancer; (3) oncologist-
estimated prognosis of 6–24 months; (4) English speaking;
and (5) able to complete baseline questionnaires. Patients
were excluded if: they scored <4 on the Callahan Cognitive
Screen; [18] had an active Axis I psychiatric condition
(e.g., schizophrenia, bipolar disorder) or substance use
disorder; or had uncorrectable hearing disorder or unreliable telephone service. Patient participants were asked to
nominate a family caregiver, defined as “a person who
knows you well and is involved in your medical care”
to participate in a parallel intervention. Patients were not
excluded if they did not have a participating caregiver.
There were no other caregiver eligibility criteria. After
completing baseline measures, patients and their caregiver
coparticipants, if they had one, were randomly assigned
to receive early or delayed intervention.

The ENABLE III early palliative care
intervention
The ENABLE III intervention was initially developed in 1998
as a Robert Wood Johnson demonstration project to integrate early palliative care with oncology care and has now
been refined and evaluated in two large multisite RCTs [1,

© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
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2, 19–21]. Details of the intervention are described elsewhere
[1, 2, 20] and on the National Cancer Institute’s Research-
tested Intervention Programs website (rtips.cancer.gov/rtips/
index.do). Briefly, the ENABLE III intervention consisted
of: (1) an outpatient palliative care assessment following
National Consensus Guidelines [22] (caregivers invited to
attend); (2) a series of individualized phone sessions delivered weekly by nurse coaches following a guidebook called
Charting Your Course (patients: 6 sessions; caregivers: 3
sessions); and (3) monthly follow-up to reinforce previous
content as needed or to address new issues. Patients and
caregivers received their one-on-one sessions with a separate
nurse coach. The first three patient and caregiver sessions
addressed decision-
making and problem-
solving strategies
(based upon the principles of Problem-
solving Treatment
and the COPE program) [23–26], communication skills,
advance care planning, and symptom management. The
patient portion of ENABLE III included three more sessions
that incorporated the Outlook life review intervention developed by Steinhauser and colleagues [27, 28].

Data collection and measures
Caregiver outcome measures were collected by telephone
by a study coordinator blinded to group assignment at
baseline and every 6 weeks for 24 weeks and then every
12 weeks until the patient’s death or study completion.
Caregiver QOL was measured using the 35-item Caregiver
QOL-Cancer Scale (CQOL-C) (score range 0–140: higher
scores = worse QOL) [29]. Domains of the CQOL-
C
include physical, emotional, and spiritual wellbeing related
to caregiving and relationship quality with the care recipient. Internal consistency has been reported as 0.91 and
a test–retest reliability as 0.95. Caregiver depressed mood
was measured using the 20-item Center for Epidemiological
Studies Depression (CES-D) scale (score range 0–60; higher
scores = higher depressed mood; >16 = clinically significant depression) [30, 31]. Caregiver burden was measured
using the 14-item Montgomery Borgatta Caregiver Burden
Scale (MBCB) that includes objective, demand, and stress
burden subscales (subscales α = 0.88, 0.74 and 0.84,
respectively) [32, 33]. Objective burden is defined as
interference with the caregiver’s private, social and recreational time, and normal daily routine (e.g., restrictions
on vacations and trips, amount of time for friends, amount
of personal privacy). Demand burden is defined as the
degree of strain on caregivers due to feeling that their
care recipients are overly demanding (e.g., attempts by
care recipient to manipulate caregiver, unreasonable care
recipient demands and requests). Stress burden is defined
as the emotional strain felt by caregivers due to caregiving
tasks (e.g., life tension, anxiety, depression about the care
recipient relationship).

© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Statistical methods
t-
Tests and Pearson’s chi-
square were used to examine
demographic and baseline patient outcome differences
between patients with and patients without a caregiver.
Variables with significant differences between groups were
included as covariates in survival analyses (i.e., variables
significantly associated with having a family caregiver).
Cox proportional hazards regression analyses [34] were
used to model: (1) the association between caregiver
coparticipant presence/absence and survival (with and
without adjustment for baseline covariates) and (2) the
association between caregivers’ QOL, depressed mood, and
burden (objective, demand, and stress burden) measured
both at baseline and at the last occasion before patients’
death and patient survival. Patients with missing covariate
data were excluded as needed for each Cox model.

Results
Table 1 lists caregiver demographic characteristics. The
mean age was 59.4 years. Most caregivers were female
(78.0%, n = 96); White race (92.7%, n = 114); Protestant
(33.3%, n = 41); married or living with a partner (91.9%,
n = 113); employed full or part time (49.6%, n = 61);
and were the patient’s spouse/partner (75.6%, n = 93).
The diagnoses of the care recipients were lung (43.1%,
n = 53), gastrointestinal (25.2%, n = 31), genitourinary
(8.1%, n = 10), breast (8.1%, n = 10), hematologic (5.7%,
n = 7), and other solid tumor cancers (10.6%, n = 13).
Table 2 lists patient characteristics and compares groups
of patients with (n = 123) and without caregivers (n = 84).
Compared to patients without caregivers, patients with
caregivers were older (62.4 vs. 65.7, P = 0.02); male (38.1%
vs. 62.6%, P < 0.01); married or living with a partner
(53.6% vs. 73.2%, P < 0.01); and were more likely to
have a living will or durable power of attorney (34.5%
vs. 49.6%, P = 0.05). There were no differences in patients’
other demographics, Charlson scores, Karnofsky
Performance Status (KPS), symptom impact, depressed
mood (CES-
D), QOL (FACIT-
Pal), clinical trial enrollment, presence of a do-not-resuscitate (DNR) order, or
intervention group.

Caregiver status and patient survival
In a Cox regression model that included the caregiver
status predictor and no covariates, having a caregiver
coparticipant was associated with reduced patient survival
(n = 207, Wald(1) = 4.31, HR = 1.52, CI: 1.02–2.25,
P = 0.04) (see Fig. 1). In a model that included covariates correlating significantly with caregiver status (patient
age, patient gender, marital status [married/unmarried],
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Table 1. Caregiver Demographic Characteristics (N = 123).
Characteristic
Age, years
Mean
SD
Sex
Female
Male
Missing
Race
White people
Other
Missing/no response
Marital Status
Married or living with partner
Never Married
Divorced or separated
Widowed
Missing/no response
Education
High school or GED; some college or
technical school
≥ College graduate
<High school graduate
Missing/no response
Employment status
Full or part time
Retired
Not employed
Missing/no response
Religious affiliation
Protestant
Catholic
Jewish
None
Other
Missing/no response
Relationship to Patient
Spouse/partner
Sibling
Son or daughter
Parent
Other
Missing/no response
Primary disease site of patient
Lung
GI
GU
Breast
Hematologic
Other solid tumor

No.

%

59.4
11.7
96
26
1

78.0
21.1
.8

114
5
4

92.7
4.1
3.3

113
4
3
2
1

91.9
3.3
2.4
1.6
.8

70

56.9

51
1
1

41.5
.8
.8

61
35
25
1

49.6
28.5
20.3
.8

41
36
2
23
15
6

33.3
29.3
1.6
18.7
12.2
4.9

93
7
14
7
1
1

75.6
5.7
11.4
5.7
.8
.8

53
31
10
10
7
13

43.1
25.2
8.1
8.1
5.7
10.6

and advance directive status [see Table 2]), caregiver status
was not associated with reduced survival (n = 205,
Wald(1) = 1.33, HR = 1.28, CI: 0.84–1.96, P = 0.25);
however, marital status was significantly associated with
reduced survival (n = 205, Wald(1) = 4.33, HR = 1.62,
CI: 1.03–2.56, P = 0.04). Because caregiver status was
significantly associated with marital status, we conducted
856

a Cox regression analysis that included caregiver status,
marital status, and their interaction as simultaneous predictors while covarying patient age, gender, and advance
directive status. In this model, caregiver status (n = 205,
Wald(1) = 6.25, HR = 2.62, CI: 1.23–5.59, P = 0.01),
marital status (n = 205, Wald(1) = 8.79, HR = 2.92, CI:
1.44–5.91, P = 0.003), and their interaction (n = 205,
Wald(1) = 5.18, HR = 0.35, CI: 0.14–0.87, P = 0.02)
were significant predictors of survival. The interaction
took the form such that caregiver status was a significant
predictor of survival among unmarried but not among
married patients. Hence, when Cox analyses were conducted separately, caregiver status was a significant predictor of reduced survival among unmarried patients
(Wald = 5.19, HR = 2.44, CI: 1.13–5.25, P = 0.02), but
not among married patients (Wald = 0.37, HR = 0.86,
CI: 0.52–1.42, P = 0.55). In order to illustrate this effect,
a fourfold categorical variable was created (caregiver present/married, caregiver present/unmarried, caregiver
absent/married, caregiver absent/unmarried). When this
variable was entered in a Cox regression model covarying
patient age, gender, and advance directive status, it was
a significant predictor of patient survival (Wald = 8.79,
P = 0.02). Kaplan–Meier survival curves were generated
for these four groups (see Fig. 2). Unmarried patients
without a caregiver (indicated by the solid blue line)
experienced better survival than the other three groups.

Caregiver QOL, depressed mood, and burden
and patient survival
At baseline, caregiver QOL, depressed mood, and burden
were not predictive of patient survival. At the last measurement period before death, only caregiver demand burden
(n = 77, Wald(1) = 4.87, CI: 1.01–1.20, P = 0.03) (Fig. 3)
was significantly related to decreased survival. Caregiver
QOL (n = 93, Wald(1) = 1.14, CI: 0.99–1.02, P = 0.29),
depressed mood (n = 93, Wald(1) = 1.22, CI: 0.99–1.04,
P = 0.27), objective (n = 81, Wald(1) = 1.68, CI: 0.97–1.15,
P = 0.20) and stress burden (n = 91, Wald(1) = 1.77,
CI: 0.97–1.16, P = 0.18) were not significant.

Post Hoc analysis
In our RCT, we collected two measures of a patients’
social support that could be related to having a caregiver:
the Multidimensional Scale of Perceived Social Support
[35] and the Social Well-being subscale of the FACIT-Pal
[36]. Although both measures were related to caregiver
status such that patients with caregivers had higher ratings
of social support, neither measure was associated with
patient survival (both with and without covariates). When
these social support measures were included as covariates

© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
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Table 2. Patient characteristics.

Characteristic

All patients (N = 207)

Patients with a caregiver (N = 123)

Patients without a caregiver (N = 84)

No.

No.

No.

Age, years
Mean
64.3
SD
9.9
Male gender
109
Marital Status
Married
135
Not married
72
Education
<High school graduate
11
High school graduate
111
College graduate
85
Race
White people
200
Black people
1
Other
5
Missing
1
Religion
Catholic
65
Protestant
63
Jewish
1
None
44
Other
28
Missing
6
Employment Status
Employed
49
Retired
99
Not Employed
58
Student
1
Medical insurance
Medicare
104
Private/Commercial
71
Military
19
Medicaid
7
Uninsured
5
Missing
1
Ever smoked
145
Diagnosis
Lung
88
Gastrointestinal tract
50
Breast
23
Other solid tumor
20
Genitourinary tract
16
Hematologic malignancies
10
Charlson score
6.3
Karnofsky Performance Status
81.0
FACIT-Pal (Baseline)
126.2
CES-D (Baseline)
14.2
QUAL-E, Symptom Impact
11.7
Subscale (Baseline)
In a clinical trial at enrollment
27
Advance directive in chart at enrollment
Living will or durable power
of attorney
89
DNR order
20
Early intervention group
104
1Fisher’s

%

52.7

62.4
9.9
77

65.2
34.8

%

%

P1

62.6

62.4
9.9
32

38.1

<0.01

90
33

73.2
26.8

45
39

53.6
46.4

<0.01

5.3
53.6
41.1

6
67
50

4.9
54.5
40.7

5
44
35

6.0
52.4
41.7

0.92

96.6
.5
2.4
.5

118
0
4
1

96.7
0
3.3
.01

82
1
1
0

97.6
1.2
1.2
0

0.31

31.4
30.4
.5
21.3
13.5
2.9

34
42
1
25
16
5

27.6
34.1
.8
20.3
13.0
4.1

31
21
0
19
12
1

36.9
25.0
0
22.6
14.3
1.2

0.41

23.7
47.8
28.0
.5

27
61
35
0

22.0
49.6
28.5
0

22
38
23
1

26.2
45.2
27.4
1.2

0.56

50.2
34.3
9.2
3.4
2.4
.5
70.1

64
42
12
4
1
0
87

52.0
34.1
9.8
3.3
.8
0
70.7

40
29
7
3
4
1
58

48.2
34.9
8.4
3.6
4.8
1.2
69.0

0.47

42.5
24.2
11.1
9.7
7.7
4.8
1.7 (SD)
10.3 (SD)
21.3
10.1
3.7 (SD)

53
31
10
12
10
7
6.2
81.1
126.6
13.3
11.6

43.1
25.2
8.1
10.6
8.1
5.7
1.6 (SD)
11.0 (SD)
19.7 (SD)
8.8 (SD)
3.7 (SD)

35
19
13
8
6
3
6.3
80.8
125.6
15.5
11.8

0.02

0.80

41.7
22.6
15.5
9.5
7.1
3.6
2.0 (SD)
9.3 (SD)
23.4 (SD)
11.6 (SD)
3.6 (SD)

0.68

0.65
0.84
0.75
0.14
0.61

13.0

16

13.0

11

13.1

0.71

43.0
9.7
50.2

60
13
61

49.6
11.7
51.2

29
7
42

34.5
8.5
49.4

0.05
0.63
0.95

exact or Pearson’s chi-square test for categorical variables and t-test for continuous variables. DNR, do-not-resuscitate.

© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
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Figure 1. Patient survival curves by caregiver coparticipant presence/
absence. Cox proportional hazards model with no covariates.

J. Nicholas Dionne-Odom et al.

Figure 3. Adjusted survival curves by high and low caregiver burden
using median split. Cox proportional hazards model adjusted for
intervention group.

interaction (n = 203, Wald(1) = 5.62, HR = 0.33, CI:
0.13–0.83, P = 0.02).

Comment

Figure 2. Adjusted survival curves by caregiver and marital status. Cox
proportional hazards model adjusted for patient age, gender, and
presence of an advance directive and/or durable power of attorney.

along with gender, age, and advance directive status, the
results for caregiver and marital status remained essentially
unchanged as shown in these results: caregiver status
(n = 203, Wald(1) = 6.90, HR = 2.89, CI: 1.31–6.40,
P = 0.009), marital status (n = 203, Wald(1) = 9.10,
HR = 3.11, CI: 1.49–6.49, P = 0.003), and their
858

We conducted a secondary analysis of the ENABLE III
RCT data to examine whether advanced cancer patients’
higher survival would be associated with having a family
caregiver, higher caregiver quality-of-life (QOL), and lower
caregiver depression. Contrary to our hypothesis, patients
with a caregiver coparticipant had lower survival compared
to those without. This finding was mostly attributable to
the higher survival of unmarried patients without caregiver
coparticipants. Of interest, higher caregiver demand burden
was associated with lower survival, while caregiver QOL,
depression, objective burden, and stress burden were not.
This is the first study to show a significant relationship
between the survival of advanced cancer patients and
family caregivers’ presence and burden.
It is unclear why patients with a caregiver had shorter
survival compared with those patients in the trial who
did not. We offer two possible explanations. First, patients
who had a high-
disease burden might have had more
daily health needs that required the presence and assistance
of a family caregiver. This high-disease burden might itself
be associated with shorter survival; hence having a caregiver might represent sicker patients with a poorer prognosis. However, the available data we collected of potential
markers of disease severity did not support this explanation. We found no detectable differences between those

© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
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with and without a caregiver in baseline cancer diagnoses,
Charlson scores, KPS scores, symptom impact, depressed
mood, QOL, or clinical trial enrollment (see Table 2). It
could be that there are other markers of disease severity
that would better predict patient survival and needing a
family caregiver. Thus, we recommend that this be explored
in future studies.
A second potential explanation for our results could
relate to patients’ self-perceived burden on their family
caregivers [37–40]. When debilitating illnesses, such as
cancer, constrain a patients’ ability to care for themselves
thereby necessitating assistance from family members, it
is possible that these patients begin to see themselves as
an undue burden on others. There is some evidence to
suggest that this reluctance to burden others may result
in depression [40] and impact one’s health behaviors
and preferences for treatment. For example, a study by
Lee and colleagues [38] of 326 patient-
caregiver dyads
with distant stage cancers found that both higher patient
self-perceived burden and higher caregiver burden scores
were associated with lower preferences for life-sustaining
treatments. While evidence is lacking in our study to
directly support the mechanism of a patient’s reluctance
to burden others, it is notable that compared to patients
without caregivers, a higher proportion of patients with
caregivers had a living will or durable power of attorney
(see Table 2).
When conducting these analyses, we found it puzzling
that just over half of the patient samples with no caregiver
coparticipants were married (54%). This appears to challenge the adequacy of caregiver coparticipation as a proxy
variable for caregiver status since it is reasonable to assume
that these married patients may have been receiving some
kind of assistance from their spouse. To clarify this puzzle, we included marital status in the Cox regression
analysis as a predictor in the 4-group Kaplan–Meier curves
(Fig. 2). This analysis revealed two important insights.
First, being married was highly associated with having a
caregiver coparticipant (Table 2). Second, the addition of
marital status along with caregiver status as predictor
variables in the Cox regression showed that the significant
association with survival was maintained in the same
negative direction, such that having a spouse was also
associated with lower survival. This is consistent with the
4-
group Kaplan–Meier curves demonstrating that those
patients who were unmarried with no caregiver coparticipant had the better survival in comparison to everyone
else who was either married and/or had a caregiver coparticipant. Our interpretation of this is that those 54% of
married patients with no caregiver coparticipant did in
reality have a spouse who may have been providing support, however, this continued to be associated with
decreased survival.

© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
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We propose several explanations for these findings. First,
while numerous studies report a protective effect of marriage on cancer mortality [41–47], other studies find marriage associated with lower survival [48] (which is consistent
with our findings). Alternatively, the relationship may vary
depending on the history of a person’s marital status: for
example, in a meta-
analysis of the association of social
networks with cancer mortality [49], survival was lowest
for individuals who were never married compared to
individuals who were divorced, separated or widowed. In
our analyses, marital status was operationalized as married/unmarried and hence it is likely that our unmarried
patient group reflects a sample that is heterogeneous with
regard to marital status history, making it difficult to
interpret how marital status drives the findings.
Second, despite controlling for gender in our analyses,
unmeasured factors associated with gender may explain
our strong study results. Lending support for this hypothesis, a meta-analysis of 1,365 nonsmall cell lung cancer
patients by Siddiqui and colleagues [50] found that unmarried females had higher overall survival than both married
and unmarried males. This is especially compelling given
that in our study, patients without a caregiver were largely
unmarried and female.
Finally, our measure of marital status does not necessarily indicate the quality of patients’ relationships and
social support networks. A substantial body of literature
has shown that the quality of relationships and social
support have a significant impact on patients’ health and
survival [51, 52]. In post hoc analyses, social support did
correlate with having a caregiver coparticipant. However,
neither the MSPSS nor the FACIT-Pal social well-being
subscale was related to patient survival. Furthermore,
inclusion of these social support measures did not change
the results of the final model. This suggests that while
the constructs of “social support” and “family caregiver”
have related features, there are dimensions of having a
family caregiver not related to social support that are
associated with patient survival. Future research should
examine how different types of social support, including
the unique type of social support delivered by family
caregivers, influence patients’ health and longevity.
For patients with a family caregiver, lower survival was
associated with higher caregiver demand burden. That is,
the patients of caregivers who perceived care recipients
and their care to be overly demanding had a higher risk
of death. Mirroring the first explanation above, patients
with more severe and progressive life-limiting illness may
have a greater need for assistance from caregivers that
would impact a caregiver’s normal daily routine and sense
of a patient’s overly demanding situation; however, we
found no differences in these patients’ markers of disease
severity at baseline.
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While provocative, these findings are subject to several
limitations. First, this was not a prospective, planned
analysis. Second, as is common across studies of the seriously ill, we experienced significant caregiver attrition
(32%) that could have resulted in a selection bias. It is
reasonable to conjecture that those caregivers experiencing
higher burden discontinued the study; however, as reported
in the trial’s primary paper [2], we found no significant
associations between attrition and caregiver demographics
and outcomes. Third, this study included few caregivers
and patients of a minority racial group, whose burden
has been shown to differ from Whites [53], thus limiting
generalizability. Fourth, it is not entirely known what
proportion of patients who did not elect to have a caregiver participate did in fact have close family and friends
who assisted them in some way with their care. In other
words, patients with or without caregiver co-participants
may not equate with actual caregivers available to patients.
Future studies will benefit from having more detailed
information about family support regardless of whether
patients elect a caregiver to co-participate.
To conclude, we believe the results of this analysis are
surprising relative to current literature and raise more
questions than are answered. However, these findings are
important as they serve to challenge our assumptions
about the impact of family caregiving on patient outcomes.
We echo what the Institute of Medicine [6, 54] and others [16, 55] have recently emphasized, namely that there
is a critical need to prioritize and place special emphasis
on research and interventions aimed at better understanding and supporting family caregiving for the critically ill
and dying. The scope of this need is vast, as most of
the over half million individuals with advanced cancer
who are in their last year of life [56] have a family member or close friend who assists them on a daily basis.
Not only are these family caregivers encumbered with
delivering nearly all of a patient’s daily care, they are
burdened with witnessing someone close to them struggle
with life-limiting illness. Hence, it is imperative that palliative and oncology clinicians’ work together to ensure
that these caregivers are supported in their role.
Understanding how to best provide this support will be
greatly benefited by continuing to improve our understanding of the complex dynamic between seriously ill
patients and their family caregivers.
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